Business

LiveWire Ergogenics, Inc. Announces Analyst Coverage Initiated By Stock Watch Index

LiveWire Ergogenics, Inc. Announces Analyst Coverage Initiated By Stock Watch Index.

articleLivewire Ergogenics, Inc.August 16, 20173/company/livewire-ergogenics/news/livewire-ergogenics-inc-announces-analyst-coverage-initiated-by-stock-watch-index
LiveWire Ergogenics, Inc. Announces Analyst Coverage Initiated By Stock Watch Index

About this update from Livewire Ergogenics, Inc.

[{"type":"text","content":"\n \n \n LiveWire Ergogenics, Inc. Announces Analyst Coverage Initiated By Stock Watch Index\n \n \nLiveWire Ergogenics, Inc. Announces Analyst Coverage Initiated By Stock Watch Index\n \n ANAHEIM, CA--(Marketwired - Aug 16, 2017) - LiveWire Ergogenics, Inc. (OTC PINK: LVVV), a company focused on research partnerships, product development and commercialization of cannabinoid-based products, is pleased to announce that Stock Watch Index has initiated equity analyst coverage on LVVV. \n The initiation research report on LVVV, dated August 16, 2017, was produced by SWI's founder and Chief Analyst Rainer Poertner and will be followed up by additional reports consistently informing the investment community about LVVV's activities and progress.\n SWI Research is a division of StockWatchIndex, a well informed and intimately connected information marketing service with a highly trafficked website, widely read newsletter publication \"Rise Above the Noise\" and a broad Social Media network. SWI provides financial research and information marketing services that generate increased and lasting market exposure for public companies in the investment community.\n The report is available by visiting http://stockwatchindex.com/livewire-ergogenics/ \n About LiveWire Ergogenics, Inc.\n LiveWire Ergogenics, Inc. (LVVV) is focused on identifying and monetizing current and future trends in the health and wellness industry. The Company's focus is on research partnerships to explore the application of cannabinoid-based products to target specific ailments or conditions with a large \"sufferer\" population for human and veterinarian applications, the cloning of cannabis strains to produce positive medicinal results, dosing verification of zero pesticide products for quality brands and development and licensing of high-quality cannabinoid based products and services. The team at LiveWire Ergogenics has a passion for research and is committed to generate innovative ideas and produce high-quality products that satisfy an increasing demand in this fast-growing industry.\n Forward-Looking Statements\n Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements may include, without limitation, financial projections, statements regarding the plans and objectives of ...

More updates from Livewire Ergogenics, Inc.